scholarly journals Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein

2010 ◽  
Vol 167 (2) ◽  
pp. 186-192 ◽  
Author(s):  
Jaime Henrique Amorim ◽  
Bruna F.M.M. Porchia ◽  
Andrea Balan ◽  
Rafael C.M. Cavalcante ◽  
Simone Morais da Costa ◽  
...  
2010 ◽  
Vol 150 (1-2) ◽  
pp. 49-55 ◽  
Author(s):  
Lan Jiang ◽  
Jun-Mei Zhou ◽  
Yue Yin ◽  
Dan-Yun Fang ◽  
Yun-Xia Tang ◽  
...  

2013 ◽  
Vol 2 (3) ◽  
pp. 114-122
Author(s):  
Yong- hong Yang ◽  
Xue-li Zheng ◽  
Lei-zi Qing ◽  
Pin-ting Zhu ◽  
Jing Pan ◽  
...  

Abstract Obejective The domain Ⅲ of dengue virus type 2 envelope was cloned and expressed in Escherichia coli and the recombinant protein inhibited virus effect was tested. Methods In this study, the domain Ⅲ (DⅢ) protein of the dengue virus type-2 (DENV-2) envelope (E) antigen was expressed in Escherichia coli by fusion with a carrier protein. The protein was purified using enzymatic cleavage and affinity purification. Rabbit immunization and antibody detection was carried out. Inhibition of DENV-2 infection was observed by DENV-2 EDⅢ protein and its immunity rabbits serum. Results The recombinant expression DENV-2 EDⅢ protein plasmid was constructed successfully. After isopropyl thiogalactoside induction, a specific soluble 29 kD protein was obtained, and the expression product accounted for 68.87% of the total protein of the cell lysate. Western blotting demonstrated the reactivity of the recombinant protein with his-tag and DENV (Ⅰ-Ⅳ) monoclonal antibodies. The protein was purified using enzymatic cleavage and affinity purification. The purified recombinant EDⅢ protein inhibited the entry of DENV-2 into BHK-21 cells. DENV-2 plaque neutralization assays were carried out using serially diluted antibodies against EDⅢ protein. At a 1:16 dilution, the antibodies produced at least 90% neutralization of the DENV-2 virus. Furthermore, the antibodies continued to exhibit high neutralization effects (approximately 80%) until the anti-EDⅢ antibody titer reached 1:1 024. Conclusions DENV-2 EDⅢ was cloned and expressed successfully. DENV-2 EDⅢ protein could be useful in the development of inexpensive dengue vaccine. The data also suggested that DENV-2 employed an attachment molecule or receptor for its entry into C6/36 mosquito cells.


2013 ◽  
Vol 94 (11) ◽  
pp. 2437-2448 ◽  
Author(s):  
J. M. Carr ◽  
T. Kua ◽  
J. N. Clarke ◽  
J. K Calvert ◽  
J. R. Zebol ◽  
...  

Sphingosine kinase 1 (SphK1) is a lipid kinase with important roles including regulation of cell survival. We have previously shown reduced SphK1 activity in cells with an established dengue virus type-2 (DENV-2) infection. In this study, we examined the effect of alterations in SphK1 activity on DENV-2 replication and cell death and determined the mechanisms of the reduction in SphK1 activity. Chemical inhibition or overexpression of SphK1 after established DENV-2 infection had no effect on infectious DENV-2 production, although inhibition of SphK1 resulted in enhanced DENV-2-induced cell death. Reduced SphK1 activity was observed in multiple cell types, regardless of the ability of DENV-2 infection to be cytopathic, and was mediated by a post-translational mechanism. Unlike bovine viral diarrhea virus, where SphK1 activity is decreased by the NS3 protein, SphK1 activity was not affected by DENV-2 NS3 but, instead, was reduced by expression of the terminal 396 bases of the 3′ UTR of DENV-2 RNA. We have previously shown that eukaryotic elongation factor 1A (eEF1A) is a direct activator of SphK1 and here DENV-2 RNA co-localized and co-precipitated with eEF1A from infected cells. We propose that the reduction in SphK1 activity late in DENV-2-infected cells is a consequence of DENV-2 out-competing SphK1 for eEF1A binding and hijacking cellular eEF1A for its own replication strategy, rather than a specific host or virus-induced change in SphK1 to modulate viral replication. Nonetheless, reduced SphK1 activity may have important consequences for survival or death of the infected cell.


2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Laura C. Laurella ◽  
Fernanda M. Frank ◽  
Andrea Sarquiz ◽  
María R. Alonso ◽  
Gustavo Giberti ◽  
...  

The aim of this study was to investigate the antiprotozoal and antiviral activities of four ArgentineanMikaniaspecies. The organic and aqueous extracts ofMikania micrantha, M. parodii, M. periplocifolia,andM. cordifoliawere tested onTrypanosoma cruziepimastigotes,Leishmania braziliensispromastigotes, and dengue virus type 2. The organic extract ofM. micranthawas the most active againstT. cruziandL. braziliensisexhibiting a growth inhibition of77.6±4.5% and84.9±6.1%, respectively, at a concentration of 10 μg/ml. The bioguided fractionation ofM. micranthaorganic extract led to the identification of two active fractions. The chromatographic profile and infrared analysis of these fractions revealed the presence of sesquiterpene lactones. None of the tested extracts were active against dengue virus type 2.


Sign in / Sign up

Export Citation Format

Share Document